-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Rxn5ZXys2nVKQfFCmySV1GoG0vcDqU4S8rLgzKyDgWz/8yncBp/VZhoCJlPO4ku3 nDiBpXBEv23d9OKgIgeVtw== 0001230295-05-000146.txt : 20050705 0001230295-05-000146.hdr.sgml : 20050704 20050705143325 ACCESSION NUMBER: 0001230295-05-000146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050630 FILED AS OF DATE: 20050705 DATE AS OF CHANGE: 20050705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TENDLER DAVID CENTRAL INDEX KEY: 0001210437 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 05936219 MAIL ADDRESS: STREET 1: 120 EAST END AVE CITY: NEW YORK STATE: NY ZIP: 10028 4 1 ten14.xml X0202 4 2005-06-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001210437 TENDLER DAVID C/O TENDLER BERETZ, LLC 150 E. 52ND STREET, 16TH FLOOR NEW YORK NY 10022 1 0 0 0 Common Stock, $.01 par value per share 2005-06-30 4 A 0 850 4.4100 A 21844 D Option to Purchase Common Stock, $.01 par value 4.4100 2005-06-30 4 A 0 5000 4.4100 A 2006-06-30 2015-06-30 Common Stock, $.01 par value per share 5000 5000 D These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On June 30, 2005, the fair market value of the Common Stock, based on the closing price, was $4.41. These options will become fully vested and immediately exercisable on 06/30/2006. By: Beata A. Smith as Attorney-In-Fact for 2005-07-01 -----END PRIVACY-ENHANCED MESSAGE-----